Clinical Trial Update: A Dose Ranging Study of the Aeris Polymeric Lung Volume Reduction (PLVR) System in Patients With Advanced Upper Lobe Predominant Emphysema [Phase 1]

View source ↗

Summary

Phase 1 dose-ranging trial of the Aeris Polymeric Lung Volume Reduction (PLVR) System in patients with advanced emphysema has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Emphysema

Drugs mentioned

• Aeris Polymeric Lung Volume Reduction (PLVR) System

Snippet

Sponsor: Aeris Therapeutics | Conditions: Advanced Emphysema | Phase 1 | Status: COMPLETED